Utilizing microarray screening and immunohistochemistry, researchers showed that AD patients tend to have moderately lower SORL1 DNA transcription levels in their lymphoblast and significantly decreased SORL1 protein level in their brains, especially the pyramidal neurons and frontal cortex (Scherzer et al., 2004). Here, SORL1 is linked to Alzheimer disease.